144 related articles for article (PubMed ID: 2114065)
1. Vasodilator therapy in microembolic porcine pulmonary hypertension.
McLean RF; Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1990 Jul; 71(1):35-41. PubMed ID: 2114065
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesthesiology; 1988 Apr; 68(4):552-8. PubMed ID: 3128144
[TBL] [Abstract][Full Text] [Related]
3. Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
Priebe HJ
Anesthesiology; 1992 May; 76(5):781-91. PubMed ID: 1575347
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
Cerdá E; Esteban A; de la Cal MA; Fernández A; García A
Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
Priebe HJ
Am J Physiol; 1988 Nov; 255(5 Pt 2):H1232-9. PubMed ID: 3142278
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of prostaglandin E1 and nitroprusside on pulmonary vascular resistance in children after open-heart surgery.
Rubis LJ; Stephenson LW; Johnston MR; Nagaraj S; Edmunds LH
Ann Thorac Surg; 1981 Dec; 32(6):563-70. PubMed ID: 7198428
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
Prielipp RC; McLean R; Rosenthal MH; Pearl RG
Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vasodilator effects of nitroglycerin and sodium nitroprusside in canine oleic acid-induced pulmonary hypertension.
Pearl RG; Rosenthal MH; Ashton JP
Anesthesiology; 1983 Jun; 58(6):514-8. PubMed ID: 6407362
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary vasodilator responses to nicardipine: comparison with other vasodilators.
Matot I; Neely CF
Crit Care Med; 1995 Nov; 23(11):1851-7. PubMed ID: 7587261
[TBL] [Abstract][Full Text] [Related]
11. Central hemodynamics and right ventricular function after coronary artery bypass surgery. A comparison of prostacyclin, sodium nitroprusside, and nitroglycerin for treatment of postcardiac surgical hypertension.
Kieler-Jensen N; Houltz E; Milocco I; Ricksten SE
J Cardiothorac Vasc Anesth; 1993 Oct; 7(5):555-9. PubMed ID: 8268436
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.
Cockrill BA; Kacmarek RM; Fifer MA; Bigatello LM; Ginns LC; Zapol WM; Semigran MJ
Chest; 2001 Jan; 119(1):128-36. PubMed ID: 11157594
[TBL] [Abstract][Full Text] [Related]
13. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
Delcroix M; Mélot C; Lejeune P; Leeman M; Naeije R
Anesthesiology; 1990 Jan; 72(1):77-84. PubMed ID: 2297136
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydralazine and nitroprusside on cardiopulmonary function when a decrease in cardiac output complicates a short-term increase in pulmonary vascular resistance.
Lee KY; Molloy DW; Slykerman L; Prewitt RM
Circulation; 1983 Dec; 68(6):1299-303. PubMed ID: 6640879
[TBL] [Abstract][Full Text] [Related]
15. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension.
Murali S; Uretsky BF; Armitage JM; Tokarczyk TR; Betschart AR; Kormos RL; Stein KL; Reddy PS; Hardesty RL; Griffith BP
J Heart Lung Transplant; 1992; 11(4 Pt 1):716-23. PubMed ID: 1498137
[TBL] [Abstract][Full Text] [Related]
16. Effects of vasodilators on canine cardiopulmonary function when a decrease in cardiac output complicates an increase in right ventricular afterload.
Ghignone M; Girling L; Prewitt RM
Am Rev Respir Dis; 1985 Apr; 131(4):527-30. PubMed ID: 3994147
[TBL] [Abstract][Full Text] [Related]
17. [Effects of nitroglycerin, prostaglandin E1, trimetaphan and nicardipine on systemic vascular resistance, pulmonary vascular resistance and pulmonary-systemic vascular resistance ratio in dogs].
Sha K; Furuya H; Yan S; Kuzumoto N; Furuki T; Okuda T
Masui; 1995 Jul; 44(7):944-9. PubMed ID: 7637184
[TBL] [Abstract][Full Text] [Related]
18. Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets.
Rudinsky BF; Komar KJ; Strates E; Meadow WL
Crit Care Med; 1987 Dec; 15(12):1127-30. PubMed ID: 3119293
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
